Aclarion (ACON) EPS (Weighted Average and Diluted) (2021 - 2026)
Aclarion (ACON) reported EPS (Weighted Average and Diluted) of -$1.34 for Q1 2026, up 85.62% on a YoY basis from -$0.72 in Q1 2025, and up 33.33% quarter-over-quarter from -$2.01 in Q4 2025.
Aclarion (ACON) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
Aclarion has reported EPS (Weighted Average and Diluted) for 6 years, with the latest figure at -$1.34 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 85.62% year-over-year to -$1.34; the trailing twelve-month figure through Mar 2026 stood at -$9.03 (up 99.79% YoY), and the FY2025 full-year result was -$13.61, up 99.82% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$1.34, up from -$2.01 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was -$0.3 in Q3 2022, with the low at -$79774.9 in Q4 2023.
- Historically, EPS (Weighted Average and Diluted) has averaged -$5180.0 across 5 years, with a median of -$2.75 in 2025.
- Annual changes were most pronounced in 2023 — EPS (Weighted Average and Diluted) slumped 3222600.77% — and 2025, when it jumped 99.87%.
- Aclarion's EPS (Weighted Average and Diluted) stood at -$2.48 in 2022, then plunged by 3222600.77% to -$79774.9 in 2023, then surged by 98.01% to -$1585.2 in 2024, then jumped by 99.87% to -$2.01 in 2025, then soared by 33.33% to -$1.34 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$1.34 (Q1 2026), -$2.01 (Q4 2025), and -$2.93 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 1.57 |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 0.67 |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 0.82 |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 0.41 |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -0.10 |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 0.10 |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 0.22 |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 0.02 |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 0.25 |
| 10 | Aclarion | 6.68 Mn | -12.07 Mn | 3,750.00 | -1.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.34 |
| Dec 31, 2025 | -2.01 |
| Sep 30, 2025 | -2.93 |
| Jun 30, 2025 | -2.75 |
| Mar 31, 2025 | -9.32 |
| Dec 31, 2024 | -1,585.25 |
| Sep 30, 2024 | -1,321.49 |
| Jun 30, 2024 | -1,362.83 |
| Mar 31, 2024 | -3,985.22 |
| Dec 31, 2023 | -79,774.93 |
| Sep 30, 2023 | -1.87 |
| Jun 30, 2023 | -2.83 |
| Mar 31, 2023 | -2.39 |
| Dec 31, 2022 | -2.48 |
| Sep 30, 2022 | -0.30 |
| Jun 30, 2022 | -0.47 |
| Mar 31, 2022 | -1.35 |
| Dec 31, 2021 | -1.44 |
| Sep 30, 2021 | -3.58 |